Title:
PEPTIDE FOR TREATING OR PREVENTING 4R TAUOPATHY
Document Type and Number:
WIPO Patent Application WO/2024/072143
Kind Code:
A1
Abstract:
One aspect of the present invention relates to: a pharmaceutical composition or a food composition for preventing, treating, or ameliorating 4R tauopathy, the composition comprising, as an active ingredient, one or more selected from the group consisting of a peptide including an amino acid sequence of SEQ ID NO: 1, a peptide having a sequence homology of at least 80% with the amino acid sequence, and a peptide that is a fragment thereof; or a medicinal use of the peptide for preventing, treating, or ameliorating 4R tauopathy.
Inventors:
KIM SANG JAE (KR)
Application Number:
PCT/KR2023/015104
Publication Date:
April 04, 2024
Filing Date:
September 27, 2023
Export Citation:
Assignee:
GEMVAX & KAEL CO LTD (KR)
KIM SANG JAE (KR)
KIM SANG JAE (KR)
International Classes:
A61K38/10; A23L33/18; A61P25/00; A61P25/28
Foreign References:
| KR20180064434A | 2018-06-14 | |||
| KR20200096570A | 2020-08-12 | |||
| US20150259406A1 | 2015-09-17 | |||
| US20070232584A1 | 2007-10-04 |
Other References:
ALI SHOEIBI: "Frontrunner in Translation: Progressive Supranuclear Palsy", FRONTIERS IN NEUROLOGY, FRONTIERS RESEARCH FOUNDATION, vol. 10, 22 October 2019 (2019-10-22), pages 1125, XP093156975, ISSN: 1664-2295, DOI: 10.3389/fneur.2019.01125
Attorney, Agent or Firm:
Y.P.LEE, MOCK & PARTNERS (KR)
Download PDF: